Synonyms: MMV533 | SAR121 | SAR441121
Compound class:
Synthetic organic
Comment: MMV688533 is the optimized lead from the acylguanidine series of antimalarial compounds [1]. The compound has progressed to clinical evaluation and was awarded MMV Project of the Year (2017).
The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY. |
|
No information available. |
Summary of Clinical Use ![]() |
MMV688533 has entered Phase 1 clinical assessment for malaria (NCT04323306). |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT04323306 | A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetic Profile of a Single Doses of MMV533. | Phase 1 Interventional | Medicines for Malaria Venture |